Oracle launches AI-driven patient portal
The company says its patient portal should help translate medical jargon into plain language. It’s Oracle’s latest move to stand out in the competitive EHR market.
7 companies hiring in North Carolina now
Looking for a biopharma job in North Carolina? Job postings in the area have increased. Here are seven companies with open roles.
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
Beyond the legal action, Eli Lilly is calling on healthcare providers, regulatory authorities, online platforms and even logistics companies to help stem the illegal sale of its next-generation asset for weight loss.
Lilly cracks down on black market for obesity asset retatrutide with six lawsuits Read More »
New Cato report excoriates certificate of need laws
The libertarian think tank analyzed almost 130 studies digging into the controversial laws, which require providers to get state approval before building facilities or adding new services. What it found wasn’t good.
New Cato report excoriates certificate of need laws Read More »
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
BridgeBio Pharma’s transthyretin amyloidosis medicine Attruby is off to a strong launch, while Alnylam lowered full-year sales guidance for competitor Amvuttra.
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations Read More »
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset
Mereo BioPharma’s asset, dubbed alvelestat, is set to enter Phase 3 development for AATD-LD in 2027.
Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset Read More »
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
After two rejections, Replimune has made it across the regulatory finish line with its twice-rejected therapy for advanced melanoma. Meanwhile, the last of the major pharmas, including Eli Lilly and Novo Nordisk, reported second quarter earnings, and psychedelics made headlines once again.
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight Read More »
Cómo el microbioma intestinal se comunica con el cerebro a través del nervio vago para moldear tu estado de ánimo
Si tu cuerpo fuera una gran metrópolis, en el centro de control, el cerebro toma las decisiones y gestiona las emociones. Sin embargo, en los suburbios de tu sistema digestivo habita una población inmensa: más de 30 billones de bacterias, virus y hongos que conforman el microbio …
Cómo el ritmo circadiano y la melatonina reparan tu ADN mientras duermes
Cada noche, mientras nos desconectamos del mundo y nos entregamos al sueño, en el interior de nuestras células comienza un turno de trabajo frenético. Lejos de ser un estado de inactividad, la noche es el escenario de una de las operaciones de mantenimiento más cruciales …
Cómo el ritmo circadiano y la melatonina reparan tu ADN mientras duermes Read More »
El hombre que fotografió los átomos: Jerome Karle
¿Cómo podemos diseñar medicamentos contra enfermedades complejas si no conocemos la forma exacta de las moléculas que las causan? Durante décadas, la ciencia estuvo atrapada en un callejón sin salida: sabíamos que podíamos usar rayos X para &qu …
El hombre que fotografió los átomos: Jerome Karle Read More »